Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity Study in VLBW Neonates of BSYX-A110 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating BSYX-A110 in very low birth weight neonates with Staphylococcal sepsis reports safety, pharmacokinetics, pharmacodyna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcal Sepsis

Drugs mentioned

• BSYX-A110

Snippet

Sponsor: Biosynexus Incorporated | Conditions: Staphylococcal Sepsis | Phase 2 | Status: COMPLETED